EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Fatty acid Sources: 6

Arachidonic acid

Also called: ARA, AA, C20:4n-6

An omega-6 long-chain polyunsaturated fatty acid (C20:4n-6). With DHA it is one of the two most prevalent long-chain polyunsaturated fatty acids in the brain, and most US infant formulas contain both. Adult trials usually gave ARA as a supplement, such as ARA-enriched oil capsules.

Category
Fatty acid
Forms
Arachidonic acid as ARA-enriched triglyceride oil (capsules); added with DHA to infant formula
Strongest evidence
C Limited
Reviewed
2026-10-30

Class 1 Well studied in people. A 2019 systematic review identified 14 RCTs (22 articles, 1997-2018), mostly in adults, of increased arachidonic acid intake (80-2,000 mg/day for 1-12 weeks). It excluded trials combining ARA with DHA or any other fatty acid, so all 14 tested ARA alone. [2]

Fact-checked 2026-10-30 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

4 topics studied3 body areas · strongest grade C

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Arachidonic acid does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Arachidonic acid, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Health outcomes in adults overallCA 2019 systematic review of 14 RCTs found few marked benefits of raising ARA intake from the usual 100-200 mg/day to as much as 1,000 mg/day, and too few data for any recommendation on specific health effects. [2]
Strength, power and lean mass with resistance trainingCIn an 8-week RCT of 30 strength-trained men, lean body mass, upper-body strength and peak power increased only in the ARA group. [3]
Muscle protein synthesis after resistance exerciseCIn a 4-week double-blind RCT (19 trained men, 1.5 g ARA/day versus corn-soy oil), ARA did not change muscle protein synthesis or anabolic signaling after exercise; ribosome biogenesis rose at 48 h only with ARA. [4]
Brain event-related potentials (P300) in healthy elderly menCA one-month double-blind crossover study in 25 men (240 mg/day ARA versus olive oil capsules) reported shorter P300 latency and higher P300 amplitude with ARA. [5]

Main constituents: Arachidonic acid (C20:4n-6), one of the major omega-6 fatty acids [1]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • Trials in the 2019 systematic review used 80-2,000 mg ARA per day for 1-12 weeks. [2]
  • One month of 600 mg/day ARA-enriched triglyceride containing 240 mg ARA. [5]
  • 1.5 g ARA daily for 4 weeks. [4]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Pregnancy and breastfeeding
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Interactions with medicines
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    None on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    None found

    No published information found in the sources checked.

    Details and sources
  • The 2019 systematic review found no adverse effects in adults of increased ARA intake up to at least 1,000-1,500 mg/day on blood lipids, platelet aggregation and blood clotting, immune function, inflammation or urinary excretion of ARA metabolites; higher intakes deserve further study. [2]
Regulation

Regulatory status

  • US: ODS states that since 2002 manufacturers have added DHA and arachidonic acid to most infant formulas, and most currently available US infant formulas contain both. [1]
  • US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [6]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-30). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Arachidonic acid (C20:4n-6) Fatty acids and lipids (omega-6 long-chain polyunsaturated fatty acid) [P5]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • No NDI notification naming arachidonic acid (ARA) was found in FDA's published NDI list (dated July 9, 2026; checked 2026-10-30). FDA keeps no authoritative list of ingredients marketed before October 15, 1994. [P1]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC or NTP carcinogenicity evaluation of arachidonic acid was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-30). [P2]
  • The NTP Technical Reports index (TR-001 to TR-606) lists no 2-year study of arachidonic acid (checked 2026-10-30). [P3]

Liver (NIH LiverTox)

  • No published information found in the sources checked.

Interactions with medicines

  • No published information found in the sources checked.

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; FDA may exempt a firm only by granting a petition under 111.75(a)(1)(ii). [P4]

Supply and conservation

  • No published information found in the sources checked.

Absorption in people

  • Calder et al. (2019 systematic review): ARA doses as low as 80 mg/day increased the ARA content of different blood fractions. [P6]

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • No published information found in the sources checked.

Pregnancy and breastfeeding

  • No published information found in the sources checked.

Sources for this profile

  1. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  2. IARC Monographs. List of Classifications (last update 2026-07-23; checked 2026-10-30), 2026-07-23. monographs.iarc.who.int
  3. National Toxicology Program. Technical Reports (TR series index, TR-001 to TR-606; checked 2026-10-30), 2026-10-30. ntp.niehs.nih.gov
  4. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (current text, retrieved 2026-10-30), 2026-10-30. ecfr.gov
  5. NIH Office of Dietary Supplements. Omega-3 Fatty Acids: Fact Sheet for Health Professionals (no printed update date; page last modified 2026-10-24 per page metadata), 2026-10-24. ods.od.nih.gov
  6. Calder PC, et al. A systematic review of the effects of increasing arachidonic acid intake on PUFA status, metabolism and health-related outcomes in humans. Br J Nutr 2019;121(11):1201-1214 (PMID 31130146), 2019-06. pubmed.ncbi.nlm.nih.gov
Sources

Sources

  1. NIH Office of Dietary Supplements. Omega-3 Fatty Acids: Fact Sheet for Health Professionals (no printed update date; page last modified 2026-10-24 per page metadata), 2026-10-24. ods.od.nih.gov
  2. Calder PC, et al. A systematic review of the effects of increasing arachidonic acid intake on PUFA status, metabolism and health-related outcomes in humans. Br J Nutr 2019;121(11):1201-1214 (PMID 31130146), 2019-06. pubmed.ncbi.nlm.nih.gov
  3. De Souza EO, et al. Effects of arachidonic acid supplementation on acute anabolic signaling and chronic functional performance and body composition adaptations. PLoS One 2016;11(5):e0155153 (PMID 27182886), 2016-05-16. pubmed.ncbi.nlm.nih.gov
  4. Mitchell CJ, et al. Effect of dietary arachidonic acid supplementation on acute muscle adaptive responses to resistance exercise in trained men: a randomized controlled trial. J Appl Physiol 2018;124(4):1080-1091 (PMID 29389245), 2018-04-01. pubmed.ncbi.nlm.nih.gov
  5. Ishikura Y, et al. Arachidonic acid supplementation decreases P300 latency and increases P300 amplitude of event-related potentials in healthy elderly men. Neuropsychobiology 2009;60(2):73-9 (PMID 19752581), 2009. pubmed.ncbi.nlm.nih.gov
  6. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (Content current as of 08/27/2026), 2026-08-27. fda.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in fatty acid: Algal oil (DHA and EPA) · Argan oil · Conjugated linoleic acid (CLA) · Evening primrose oil · GLA oils (borage and blackcurrant seed oil) · Krill oil · Linoleic acid · MCT oil (medium-chain triglycerides) · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.